Office of the Director, National Institutes of Health; Notice of Meeting, 64803 [2022-23229]
Download as PDF
Federal Register / Vol. 87, No. 206 / Wednesday, October 26, 2022 / Notices
consumer rates of interest on the date
that the Department of Health and
Human Services becomes entitled to
recovery. The rate cannot be lower than
the Department of Treasury’s current
value of funds rate or the applicable rate
determined from the ‘‘Schedule of
Certified Interest Rates with Range of
Maturities’’ unless the Secretary waives
interest in whole or part, or a different
rate is prescribed by statute, contract, or
repayment agreement. The Secretary of
the Treasury may revise this rate
quarterly. The Department of Health and
Human Services publishes this rate in
the Federal Register.
The current rate of 101⁄8%, as fixed by
the Secretary of the Treasury, is certified
for the quarter ended September 30,
2022. This rate is based on the Interest
Rates for Specific Legislation, ‘‘National
Health Services Corps Scholarship
Program (42 U.S.C. 254o(b)(1)(A))’’ and
‘‘National Research Service Award
Program (42 U.S.C. 288(c)(4)(B)).’’ This
interest rate will be applied to overdue
debt until the Department of Health and
Human Services publishes a revision.
David C. Horn,
Director, Office of Financial Policy and
Reporting.
[FR Doc. 2022–23308 Filed 10–25–22; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Motor Function.
Date: November 8, 2022.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
17:37 Oct 25, 2022
Jkt 259001
Contact Person: Stephanie Christine Nagle
Emmens, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–6604,
nagleemmenssc@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 20, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23270 Filed 10–25–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel RFA
Panel: Tobacco Regulatory Science B,
November 17, 2022, 9:30 a.m.–8:00
p.m., National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
which was published in the Federal
Register on October 20, 2022, 87 FR
63790, Doc 2022–22763.
This notice is being amended to
change the meeting end time from 8:00
p.m. to 8:30 p.m. The meeting is closed
to the public.
Dated: October 20, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23228 Filed 10–25–22; 8:45 am]
BILLING CODE 4140–01–P
64803
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: November 3, 2022.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: New Framework for Peer Review
Criteria, Consideration of Proposed
Establishment of ACD Working Groups, and
Other Business of the Committee.
Place: National Institutes of Health,
Building 1, One Center Drive, Bethesda, MD
20892, (Virtual Meeting).
Contact Person: Cyndi Burrus-Shaw, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–2433, shawcy@od.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to scheduling difficulties.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda will be
posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: October 20, 2022.
David W. Freeman,
Program Analyst,Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2022–23229 Filed 10–25–22; 8:45 am]
Office of the Director, National
Institutes of Health; Notice of Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 87, Number 206 (Wednesday, October 26, 2022)]
[Notices]
[Page 64803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23229]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Advisory Committee
to the Director, National Institutes of Health.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov).
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: November 3, 2022.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: New Framework for Peer Review Criteria, Consideration of
Proposed Establishment of ACD Working Groups, and Other Business of
the Committee.
Place: National Institutes of Health, Building 1, One Center
Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-2433,
[email protected].
This notice is being published less than 15 days prior to the
meeting due to scheduling difficulties.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda will be posted before the
meeting date.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: October 20, 2022.
David W. Freeman,
Program Analyst,Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23229 Filed 10-25-22; 8:45 am]
BILLING CODE 4140-01-P